Trial Profile
A multi-national prospective study assessing efficacy and safety of nonacog gamma for perioperative use in previously-treated patients with severe or moderately severe hemophilia B.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jan 2017
Price :
$35
*
At a glance
- Drugs Nonacog gamma (Primary)
- Indications Haemophilia B
- Focus Adverse reactions; Therapeutic Use
- 11 Jan 2017 New trial record
- 06 Dec 2016 Results of all 38 surgeries assessing safety and efficacy of Nonacog gamma presented at the 58th Annual Meeting and Exposition of the American Society of Hematology